Expression of Epithelial Markers in Nodular Fasciitis and Fibromatosis: An Immunohistochemical Study.
S Yasir, M Nadji, P Kurzawa, GP Nielsen, A Rosenberg - University of Miami, Jackson Memorial Hospital, FL; Great Poland Cancer Centre, Poznan; Massachusetts General Hospital, Boston
Loss of ASS1 Expression in Myxofibrosarcoma Via Promoter Hypermethylation: Prognostic and Potential Therapeutic Implications.
C-F Li, L-T Chen, Y-H Wang, Y-L Shiue, H-Y Huang - Chi-Mei Hosp., Tainan, Taiwan; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan; NCRI, NHRI, Tainan, Taiwan; Chang Gung Memorial Hosp., Kaohsiung, Taiwan
Molecular Analysis of Extra-Axial Hemangioblastoma. A Study of 6 Cases.
LA Muscarella, J Lamovec, P Parrella, N Zidar, L D'Agruma, M Bisceglia, V Guarnieri, M Coco, JC Fanburg-Smith, L Zelante, M Michal - Hospital, San Giovanni Rotondo, Foggia, Italy; Institute of Oncology, Ljubljana, Slovenia; Medical Faculty, University of Ljubliana, Slovenia; Nova Fairfax Hospital, Falls Church, VA; IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Foggia, Italy; Charles University Medical Faculty, Plzen, Czech Republic
TFE3-Positive Perivascular Epithelioid Cell Tumor as a Distinct Entity: Morphological, Immunohistochemical, and Molecular Analyses.
M Tanaka, K Kato, K Gomi, M Yoshida, K Kurosawa, H Kigasawa, Y Ohama, G Taylor, Y Tanaka - Kanagawa Children's Medical Center, Yokohama, Japan; Ibaraki Children's Hospital, Mito, Japan; Hospital for Sick Children, Toronto, Canada
ROR2: A Potential Therapeutic Target in Soft Tissue Tumors.
B Edris, I Espinosa, AH Beck, C-H Lee, AJ Lazar, D Lev, JA Fletcher, RB West, R Nusse, M van de Rijn - Stanford University School of Medicine, CA; Universitat Autonoma de Barcelona, Spain; Vancouver General Hospital, BC, Canada; MD Anderson Cancer Center, Houston, TX; Harvard Medical School, Boston, MA
CSF1-Response Signature Is Associated with Tumor Angiogenesis in Non-Gynecological Leiomyosarcoma.
I Espinosa, A Beck, B Edris, C-H Lee, R West, M van de Rijn - Stanford University School of Medicine, CA; Universidad Autonoma de Barcelona, Spain; University of British Columbia, Vancouver, Canada
Molecular Alteration Implicated in Malignant Transformation of Peripheral Nerve Sheath Tumors (PNST): A Window to New Therapeutic Approaches.
C Romagosa, C Serrano, S Simonetti, J Hernandez-Losa, S Baguer, R Orellana, T Moline, R Somoza, S Ramon y Cajal - Hospital Vall d'Hebron, Barcelona, Spain; Hospital de Sant Pau, Barcelona, Spain; Hospital Parc Tauli, Sabadell, Spain
Oncofetal Protein IMP3: A Specific Biomarker That Distinguishes Leiomyoma from Leiomyosarcoma.
K Cornejo, M Shi, Z Jiang - UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester
Frequency of MDM2 Amplification in Malignant Peripheral Nerve Sheath Tumors: Non-Correlation with Tumor Grade, Cellularity and MIB1 Proliferation Index.
ML Wallander, LJ Layfield - ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT; University of Utah School of Medicine and ARUP Laboratories, Salt Lake City
Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic Tumor.
X Wang, C Krishnan, E Nguyen, KJ Mayer, JL Oliveira, JE Yi, P Yang, MJ Yaszemski, A Maran, MR Erickson-Johnson, AM Oliveira - Mayo Clinic, Rochester, MN; Dells Children's Medical Center of Central Texas, Austin; Mayo Medical School, Rochester, MN; Mayo Clinic, Rocheser, MN
Detection of MDM2/CDK4 Amplification in Lipomatous Soft Tissue Tumors from Formalin-Fixed, Paraffin-Embedded Tissue: Comparison of Multiplex Ligation-Dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH).
D Creytens, S Ah Schoondermark-Stolk, E-J Speel, J van Gorp, P Pauwels - University Hospital Antwerp, Antwerp, Belgium; Diakonessen Hospital Utrecht, Utrecht, Netherlands; University Hospital Maastricht, Netherlands
Detection of MDM2 and CDK4 by Fluorescence In Situ Hyridization, Immunohistochemistry and Real-Time PCR in Liposarcoma: Prognostic Significance Based on the Molecular Diagnosis.
JH Cho, J Lee, SW Seo, JO Park, SJ Kim, G Ahn, Y-L Choi - Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
MDM2-p53 Pathway Status in Clinical Samples of Well-Differentiated and Dedifferentiated Liposarcoma.
A Kumagai, T Motoi, A Yoshida, T Imamura, T Fukusato - Teikyo University School of Medicine, Tokyo, Japan; University of Tokyo, Japan; Teikyo University Hospital, Tokyo, Japan
Primary Retroperitoneal Liposarcomas: Mitoses in Non-Adipogenic Zones Correlate with Survival.
S Chopra, Y Li, D Gui, FC Eilber, SM Dry - UCLA, Los Angeles, CA; Tata Medical Center, Kolkata, India
Activation of the PI-3-Kinase Pathway and Prognostic Factors in Myxoid Liposarcoma.
EG Demicco, KE Torres, M Ghadimi, C Columbo, T Peng, D Lev, W-L Wang, AJ Lazar - The University of Texas M.D. Anderson Cancer Center, Houston